ID

15861

Descripción

Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE); ODM derived from: https://clinicaltrials.gov/show/NCT02425592

Link

https://clinicaltrials.gov/show/NCT02425592

Palabras clave

Versiones (1)
  1. 16/6/16 16/6/16 -
Subido en

16 de junio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT02425592

Inglés

Eligibility Prostate Cancer NCT02425592

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 30-80
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
completed mri fusion prostate biopsy either in the past that demonstrated gleason 6 prostate cancer and are either currently enrolled in active surveillance or are interested in active surveillance, or have completed an mri fusion prostate biopsy at the first visit that demonstrates gleason 6 prostate cancer and are interested in active surveillance
Descripción

MRI Ultrasound Fusion Guided Biopsy | Gleason Grading System | Prostate carcinoma | Active surveillance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3898501
UMLS CUI [2]
C0332326
UMLS CUI [3]
C0600139
UMLS CUI [4]
C1827061
diagnosed with gleason 6 prostate cancer
Descripción

Prostate carcinoma | Gleason Grading System

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2]
C0332326
psa <20
Descripción

Prostate specific antigen measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201544
<ct3 prostate cancer
Descripción

Prostate carcinoma | TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2]
C3258246
ability to receive an mri with iv gadolinium contrast
Descripción

Magnetic Resonance Imaging | Gadolinium-based Contrast Agent Intravenous Injection | Ability

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024485
UMLS CUI [2,1]
C3249258
UMLS CUI [2,2]
C0021494
UMLS CUI [3]
C0085732
life expectancy >10 years (by physician estimate)
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
understanding and willingness to provide consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
english speaking
Descripción

Able to speak English Language

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
received treatment for prostate cancer (hormone manipulation, surgery, radiation).
Descripción

Therapeutic procedure Prostate carcinoma | Hormone manipulation | Operative Surgical Procedures | Therapeutic radiology procedure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0600139
UMLS CUI [2]
C0586971
UMLS CUI [3]
C0543467
UMLS CUI [4]
C1522449
known metastatic disease
Descripción

Metastatic Neoplasm

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2939420
high risk prostate cancer by epstein criteria
Descripción

Prostate carcinoma High risk of

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0332167
any gleason 7 or higher prostate cancer on prostate biopsy
Descripción

Prostate carcinoma | Gleason Grading System | Biopsy of prostate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2]
C0332326
UMLS CUI [3]
C0194804
inability to receive an mri with iv gadolinium contrast
Descripción

Magnetic Resonance Imaging | Gadolinium-based Contrast Agent Intravenous Injections | Unable

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024485
UMLS CUI [2,1]
C3249258
UMLS CUI [2,2]
C0021494
UMLS CUI [3]
C1299582
life expectancy <10 years
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
unwillingness to undergo monitoring and imaging studies
Descripción

Clinical study Monitoring Unwilling | Clinical study Imaging Unwilling

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C1283169
UMLS CUI [1,3]
C0558080
UMLS CUI [2,1]
C0008972
UMLS CUI [2,2]
C0079595
UMLS CUI [2,3]
C0558080
non-english speaking
Descripción

Able to speak English Language

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT02425592

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 30-80
boolean
C0001779 (UMLS CUI [1])
MRI Ultrasound Fusion Guided Biopsy | Gleason Grading System | Prostate carcinoma | Active surveillance
Item
completed mri fusion prostate biopsy either in the past that demonstrated gleason 6 prostate cancer and are either currently enrolled in active surveillance or are interested in active surveillance, or have completed an mri fusion prostate biopsy at the first visit that demonstrates gleason 6 prostate cancer and are interested in active surveillance
boolean
C3898501 (UMLS CUI [1])
C0332326 (UMLS CUI [2])
C0600139 (UMLS CUI [3])
C1827061 (UMLS CUI [4])
Prostate carcinoma | Gleason Grading System
Item
diagnosed with gleason 6 prostate cancer
boolean
C0600139 (UMLS CUI [1])
C0332326 (UMLS CUI [2])
Prostate specific antigen measurement
Item
psa <20
boolean
C0201544 (UMLS CUI [1])
Prostate carcinoma | TNM clinical staging
Item
<ct3 prostate cancer
boolean
C0600139 (UMLS CUI [1])
C3258246 (UMLS CUI [2])
Magnetic Resonance Imaging | Gadolinium-based Contrast Agent Intravenous Injection | Ability
Item
ability to receive an mri with iv gadolinium contrast
boolean
C0024485 (UMLS CUI [1])
C3249258 (UMLS CUI [2,1])
C0021494 (UMLS CUI [2,2])
C0085732 (UMLS CUI [3])
Life Expectancy
Item
life expectancy >10 years (by physician estimate)
boolean
C0023671 (UMLS CUI [1])
Informed Consent
Item
understanding and willingness to provide consent
boolean
C0021430 (UMLS CUI [1])
Able to speak English Language
Item
english speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Prostate carcinoma | Hormone manipulation | Operative Surgical Procedures | Therapeutic radiology procedure
Item
received treatment for prostate cancer (hormone manipulation, surgery, radiation).
boolean
C0087111 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0586971 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
Metastatic Neoplasm
Item
known metastatic disease
boolean
C2939420 (UMLS CUI [1])
Prostate carcinoma High risk of
Item
high risk prostate cancer by epstein criteria
boolean
C0600139 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
Prostate carcinoma | Gleason Grading System | Biopsy of prostate
Item
any gleason 7 or higher prostate cancer on prostate biopsy
boolean
C0600139 (UMLS CUI [1])
C0332326 (UMLS CUI [2])
C0194804 (UMLS CUI [3])
Magnetic Resonance Imaging | Gadolinium-based Contrast Agent Intravenous Injections | Unable
Item
inability to receive an mri with iv gadolinium contrast
boolean
C0024485 (UMLS CUI [1])
C3249258 (UMLS CUI [2,1])
C0021494 (UMLS CUI [2,2])
C1299582 (UMLS CUI [3])
Life Expectancy
Item
life expectancy <10 years
boolean
C0023671 (UMLS CUI [1])
Clinical study Monitoring Unwilling | Clinical study Imaging Unwilling
Item
unwillingness to undergo monitoring and imaging studies
boolean
C0008972 (UMLS CUI [1,1])
C1283169 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0008972 (UMLS CUI [2,1])
C0079595 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
Able to speak English Language
Item
non-english speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial